International Urology and Nephrology

, Volume 46, Issue 7, pp 1435–1440 | Cite as

Transient elastography: a new noninvasive diagnostic tool for assessment of chronic allograft nephropathy

  • V. Lukenda
  • I. MikolasevicEmail author
  • S. Racki
  • I. Jelic
  • D. Stimac
  • L. Orlic
Nephrology - Original Paper



Chronic allograft nephropathy (CAN) is the most common cause of kidney allograft failure. Protocol biopsies remain the “gold standard” in CAN recognition. However, renal allograft biopsies have numerous limitations. It is an invasive procedure connected with risk of complications, patient discomfort, and sampling errors. The aim of our study was to investigate the usefulness of transient elastography (TE) for the assessment of kidney allograft fibrosis in renal transplant recipients (RTRs).


In this cross-sectional study, we involved 52 RTRs. Renal allograft stiffness was used to assess its fibrosis by using transient elastography (Fibroscan®, Echosense, Paris, France). In 23 patients with a deterioration of graft function, percutaneous renal allograft biopsy was performed closely around the time of TE.


We have found that the renal allograft stiffness was highly negatively correlated with estimated glomerular filtration rate (eGFR) (r = −0.640; p < 0.0001). However, renal allograft stiffness showed a statistically significant difference between patients who had an eGFR > 50 ml/min per 1.73 m2 and patients with eGFR < 50 ml/min per 1.73 m2 (28 ± 2.7 vs. 33.9 ± 5.5 kPa; p = 0.0003). Also, there was a highly positive correlation between renal allograft stiffness and extent of interstitial fibrosis on renal biopsy (r = 0.727; p = 0.0001).


According to our results, parenchymal stiffness obtained by TE reflects interstitial fibrosis. Therefore, TE provides the opportunity for noninvasive screening of CAN.


Chronic allograft nephropathy Protocol biopsies Transient elastography Renal transplant recipients 


  1. 1.
    Nankivell BJ, Chapman JR (2006) Chronic allograft nephropathy: current concepts and future directions. Transplantation 81:643–654PubMedCrossRefGoogle Scholar
  2. 2.
    Nankivell BJ, Borrows RJ, Chir B et al (2003) The natural history of chronic allograft nephropathy. N Engl J Med 349:2326–2333PubMedCrossRefGoogle Scholar
  3. 3.
    Birnbaum LM, Lipman M, Paraskevas S et al (2009) Management of chronic allograft nephropathy: a systematic review. Clin J Am Soc Nephrol 4:860–865PubMedCrossRefGoogle Scholar
  4. 4.
    Arndt R, Schmidt S, Loddenkemper C et al (2010) Noninvasive evaluation of renal allograft fibrosis by transient elastography—a pilot study. Transpl Int 23:871–877PubMedGoogle Scholar
  5. 5.
    Yehia M, Matheson PJ, Merrilees MJ, Beaumont BW, Pilmore HL (2006) Predictors of chronic allograft nephropathy from protocol biopsies using histological and immunohistochemical techniques. Nephrology 11:261–266PubMedCrossRefGoogle Scholar
  6. 6.
    Rush D, Arlen D, Boucher A et al (2007) Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant 7:2538–2545PubMedCrossRefGoogle Scholar
  7. 7.
    Chapman JR, O’Connell PJ, Nankivell BJ (2005) Chronic renal allograft dysfunction. J Am Soc Nephrol 16:3015–3026PubMedCrossRefGoogle Scholar
  8. 8.
    Pereira RS, Gonul II, McLaughlin K, Yilmaz S, Mahallati H (2010) Assessment of chronic renal allograft nephropathy using contrast-enhanced MRI: a pilot study. Am J Roentgenol 194:W407–W413CrossRefGoogle Scholar
  9. 9.
    Wong GLH (2013) Transient elastography: kill two birds with one stone? World J Hepatol 5:264–274.ZZZPubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Chan HL, Wong GL, Choi PC et al (2009) Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan®) for liver fibrosis in chronic hepatitis B. J Viral Hepat 16:36–44PubMedCrossRefGoogle Scholar
  11. 11.
    Castera L, Vergniol J, Foucher J et al (2005) Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350PubMedCrossRefGoogle Scholar
  12. 12.
    Arena U, Vizzutti F, Abraldes JG et al (2008) reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 57:1288–1293PubMedCrossRefGoogle Scholar
  13. 13.
    Mikolasevic I, Racki S, Bubic I, Jelic I, Stimac D, Orlic L (2013) Chronic kidney disease and Nonalcoholic fatty liver disease proven by transient elastography. Kidney Blood Press Res 37:305–310 [Epub ahead of print]PubMedCrossRefGoogle Scholar
  14. 14.
    Mikolasevic I, Racki S, Zaputovic L, Lukenda V, Milic S, Orlic L (2013) Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. Med HypothesisGoogle Scholar
  15. 15.
    European Association for the Study of the Liver (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:167–185Google Scholar
  16. 16.
    Derieppe M, Delmas Y, Gennisson JL et al (2012) Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats. Eur Radiol 22:243PubMedCrossRefGoogle Scholar
  17. 17.
    Sommerer C, Scharf M, Seitz C et al (2013) Assessment of renal allograft fibrosis by transient elastography. Transpl Int 26:545–551PubMedCrossRefGoogle Scholar
  18. 18.
    Solez K, Colvin BB, Racusen LC et al (2007) Banff ‘05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN). Am J Transplant 7:518PubMedCrossRefGoogle Scholar
  19. 19.
    Kaplan B, Schold J, Meier-Kriesche HU (2003) Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant 3:1560–1565PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2014

Authors and Affiliations

  • V. Lukenda
    • 1
  • I. Mikolasevic
    • 2
    Email author
  • S. Racki
    • 2
  • I. Jelic
    • 2
  • D. Stimac
    • 3
  • L. Orlic
    • 2
  1. 1.Department of Internal MedicineGeneral Hospital “Dr. Josip Bencevic”Slavonski BrodCroatia
  2. 2.Department of Nephrology and Dialysis, Division of Internal MedicineUniversity Hospital Center RijekaRijekaCroatia
  3. 3.Department of Gastroenterology, Division of Internal MedicineUniversity Hospital RijekaRijekaCroatia

Personalised recommendations